MABLINK

WIPO WIPO 2020

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark MABLINK was filed as Word mark on 07/15/2020 at the World Intellectual Property Organization.

Trademark Details Last update: July 27, 2022

Trademark form Word mark
File reference 1564321
Countries Brazil Canada European Community India Japan South Korea United States of America (USA) China
Base trademark FR No. 4614472, January 15, 2020
Application date July 15, 2020
Expiration date July 15, 2030

Trademark owner

14 rue Waldeck-Rousseau
F-69006 LYON
FR

Trademark representatives

235 cours Lafayette F-69006 LYON FR

goods and services

01 Chemical, biochemical, biological and biotechnological preparations; chemical substances for the manufacture of pharmaceutical products; chemical substances for tethering molecules, in particular chemical substances for tethering molecules for cancer therapy, for research in active substances and medicines; chemical substances for the formation of antibody conjugates; chemical reagents for scientific purposes other than for medical or veterinary purposes; reagents for scientific or medical research; chemical, biochemical and biological reagents; chemicals for bioconjugation, reversible cysteine protection, surface modification, and the production of prodrugs; antibodies and antibody conjugates for scientific purposes, other than for medical or veterinary purposes; antibodies for scientific or medical research; molecules and biomolecules, especially reagents, antibody fragments, antibodies, all intended for fundamental research and development, medical research and scientific diagnosis; Diagnostic products for scientific or research use related to conjugated antibodies (medicines)
05 Pharmaceutical preparations; pharmaceutical products, in particular for the prevention or treatment of human diseases; chemical, biological and biochemical products for medical and pharmaceutical use, especially, antibody-drug conjugates or any protein combined with a drug, a polynucleotide, another protein, a chemical entity, or another functional entity, or these products used as binders or fillers; pharmaceutical preparations, in particular bioconjugates, intended for the diagnosis and treatment of diseases; antibody products, especially, antibody or protein bioconjugates for the medical diagnosis and treatment of diseases, including antibody/protein drug conjugates, antibody/protein labeled conjugates and antibody/protein imaging agent conjugates; delivery devices for antibodies; molecules and biomolecules, especially, reagents, antibody fragments, antibodies, all intended for medical diagnosis and disease treatment; pharmaceutical products, preparations and medical articles, especially antibodies, antibody conjugates and active principles and antibody conjugates; chemical reagents for medical use, in particular chemical reagents to bind molecules for medical use; chemical reagents for the functionalization of biomolecules for medical use
40 Preparation, transformation, processing of biopharmaceutical materials and especially reagents, antibodies and conjugated antibodies; processing and transformation of biopharmaceutical materials on behalf of third parties; custom manufacturing of scientific, medical, chemical, biochemical and pharmaceutical products
42 Scientific research; biological and chemical research; biochemical research and development; research and development in the pharmaceutical, biomedical and biotechnological fields, especially research into antibodies, including conjugated antibodies; research and development in the fields of biological development and biomanufacturing; laboratory research, analysis, evaluation, development and clinical testing of therapeutic, preventive and diagnostic compositions and treatments; conducting scientific and medical research for third parties; consultancy in the field of pharmaceutical research, chemistry, biotechnology; custom synthesis of chemical substances; chemical and/or biological development services; services of a chemical and/or a biologist; chemical and biological laboratory services; laboratory services concerning the modification and production of reagents, antibodies and conjugated antibodies; research and development services in the field of reagent development and production of antibodies and conjugated antibodies; conducting chemical and/or biological analyses; customized design and development of chemical reagents, antibodies and conjugated antibodies; development of chemical substances, in particular chemical substances to tether molecules and in particular technological platforms in the form of or used for the creation or improvement of antibody-drug conjugates or any protein combined with a drug, a polynucleotide, another protein, a chemical entity or another functional entity intended for industry and science
44 Medical services; medical modification of antibodies; medical services in the field of personalized medicine; advice and information services with respect to biopharmaceutical products; pharmaceutical advice; consultancy services in the field of medicine

Trademark history

Date Document number Area Entry
July 4, 2022 2022/27 Gaz KR RAW: Rule 18ter(2)(ii) GP following a provisional refusal
May 12, 2022 2022/20 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 18, 2022 2022/16 Gaz US RAW: Rule 18ter(2)(ii) GP following a provisional refusal
April 5, 2022 2022/14 Gaz CA Rejection
January 3, 2022 2022/1 Gaz KR Rejection
November 16, 2021 2021/46 Gaz BR Rejection
November 4, 2021 2021/44 Gaz JP Rejection
June 24, 2021 2021/27 Gaz RAW: Limitation
May 3, 2021 2021/19 Gaz IN Rejection
April 28, 2021 2021/17 Gaz EM Rejection
March 16, 2021 2021/13 Gaz CN Rejection
January 5, 2021 2021/1 Gaz US Rejection
July 15, 2020 2020/48 Gaz FR Registration

ID: 141564321